Reduction of Bladder Volume after BCG Immunotherapy
| Autor: | Zhengtong Lv, Changzhao Yang, Yuan Li |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Tuberculosis Urology medicine.medical_treatment Urinary Bladder Adjuvants Immunologic Humans Medicine Adverse effect Bladder cancer business.industry Carcinoma in situ Isoniazid Organ Size Immunotherapy Middle Aged medicine.disease Administration Intravesical Urinary Bladder Neoplasms BCG Vaccine Female Ofloxacin business Rifampicin medicine.drug |
| Zdroj: | Urologia Internationalis. 105:155-158 |
| ISSN: | 1423-0399 0042-1138 |
| DOI: | 10.1159/000510167 |
| Popis: | Bacillus Calmette-Guérin (BCG) immunotherapy is the most effective treatment for carcinoma in situ and high-risk non-muscle invasive bladder cancer (NMIBC). However, it can also provoke diverse side effects. We found 1 patient with a significantly and rapidly reduced bladder volume after the instillation of BCG. Few such cases and corresponding treatments have been reported. We speculated that the tuberculosis infection existed, so antitubercular therapy was given. After a 3-month oral intake of rifampicin, isoniazid, and ofloxacin, the volume of bladder returned to normal and the voiding symptoms disappeared. This case indicated that the reduction of bladder volume caused by BCG instillation could be treated with antitubercular therapy. Prompt and accurate diagnosis was important for the management. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|